SB906 HFA Burkhammer 3-13 #1

cr 3338

Delegate Burkhammer moved to amend Engrossed SB906 bill, as amended, on page 3, line 43, by striking subsection (g)  in its entirety and inserting in lieu thereof a new subsection (g) to read as follows: “(g) Notwithstanding §60A-2-204(d) of this code, if an organic psilocybin substance is approved by the United States Food and Drug Administration and rescheduled by the United States Drug Enforcement Administration and/or a composition of crystalline polymorph psilocybin is approved by the United States Food and Drug Administration and is rescheduled by the United States Drug Enforcement Administration it shall be lawful to prescribe, distribute, and market based upon the recommendations of the United States Food and Drug Administration.”

Adopted

Rejected